Upgrade to SI Premium - Free Trial

Piper Sandler Reiterates Overweight Rating on Abbott Labs (ABT)

July 15, 2025 9:03 AM
Piper Sandler analyst Adam Maeder reiterated an Overweight rating and $150.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles